Live Breaking News & Updates on Raghav mahobe

Stay informed with the latest breaking news from Raghav mahobe on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Raghav mahobe and stay connected to the pulse of your community

EU regulator backs Pfizer's RSV vaccine for infants, older adults

EU regulator backs Pfizer's RSV vaccine for infants, older adults
gazette.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gazette.com Daily Mail and Mail on Sunday newspapers.

United-states , Bengaluru , Karnataka , India , Bhanvi-satija , Raghav-mahobe , Devika-syamnath , Pfizer , European-medicines-agency , Reuters , Astrazeneca , European-commission

Kenvue quarterly sales rise on strong demand for self-care products

Kenvue on Thursday posted a
rise in quarterly sales thanks to strong demand for its
self-care and skincare brands such as Tylenol and Neutrogena.
In its first results announcement since...

Bengaluru , Karnataka , India , Raghav-mahobe , Devika-syamnath , Ananya-mariam-rajesh , Johnson , Reuters , Markets ,

Kenvue forecasts profit above estimates on self-care demand

Consumers prioritizing their dollars for essential, daily use products amid a cost-of-living crisis in some parts of the world has boosted companies such as Kenvue and peer Haleon. "While consumers may be trading down in more discretionary and traditional staple categories, we have not seen this dynamic in our portfolio," Kenvue CEO Thibaut Mongon said on a call with analysts, adding that health and wellness was still in focus. That helped Kenvue record a 12.2% rise in quarterly revenue for the self-care business, which houses over-the-counter products, or medicines that can be bought without a prescription.

Bengaluru , Karnataka , India , Devika-syamnath , Ananya-mariam-rajesh , Raghav-mahobe , Johnson , Reuters , Wall-street , Envue , Ross-profit-margin , Envue-ceo-thibaut-mongon

J&J spinoff Kenvue forecasts upbeat annual profit on self-care boost

J&J spinoff Kenvue forecasts upbeat annual profit on self-care boost
reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.

Bengaluru , Karnataka , India , Raghav-mahobe , Devika-syamnath , Sriraj-kalluvila , Ananya-mariam-rajesh , Thibaut-mongon , Thomson-reuters-trust-principles , Reuters , Wall-street , Thomson-reuters-trust

Softbank-backed Neumora's depression drug cuts symptoms in mid-stage trial

Softbank-backed Neumora Therapeutics' experimental drug navacaprant has helped reduce symptoms of depression in patients with moderate-to-severe forms of the disorder in a mid-stage trial, the company said on Tuesday.

Bengaluru , Karnataka , India , United-states , American , Henry-gosebruch , Vaibhav-sadhamta , Paul-berns , Raghav-mahobe , Pooja-desai , Thomson-reuters-trust-principles , Reuters

Westlake Village BioPartners launches $450 mln fund for biotechs

Venture capital firm Westlake
Village BioPartners on Monday launched a $450 million fund to
back early-stage biotech companies, at a time when high interest
rates have slowed funding activity.
...

Bengaluru , Karnataka , India , Raghav-mahobe , Beth-seidenberg , Mira-chaurushiya , Shinjini-ganguli , Reuters , Nasdaq , Westlake-village-biopartners , Westlake-village , Los-angeles-based

Westlake Village BioPartners launches $450 million fund for biotechs

By Raghav Mahobe (Reuters) - Venture capital firm Westlake Village BioPartners on Monday launched a $450 million fund to back early-stage biotech ...

Bengaluru , Karnataka , India , Raghav-mahobe , Beth-seidenberg , Shinjini-ganguli , Mira-chaurushiya , Nasdaq , Reuters , Westlake-village-biopartners , Westlake-village , Los-angeles-based

UnitedHealth's Lower-Than-Feared Costs Lift Profit, Shares

UnitedHealth Group's quarterly profit beat Wall Street estimates on Friday as a smaller-than-expected jump in medical costs allayed fears that a resumption in long-delayed surgical procedures would hit profit growth.

Bengaluru , Karnataka , India , John-rex , Raghav-mahobe , Pooja-desai , Vinay-dwivedi , Scott-fidel , Bhanvi-satija , Reuters , Elevance-health , Cigna

US FDA approves Sanofi-AstraZeneca's preventive RSV therapy for babies

The therapy, branded Beyfortus, was approved for preventing lower respiratory tract disease in infants born during or entering their first RSV season, and in children up to 24 months of age who remain vulnerable to severe RSV disease through their second such season. The companies plan to make Beyfortus available in the United States ahead of the upcoming RSV season, Sanofi said, adding that it plans to share more information about the therapy's price closer to the season.

Bengaluru , Karnataka , India , United-states , Shinjini-ganguli , Raghav-mahobe , Bhanvi-satija , Astrazeneca , Drug-administration , Reuters , Swedish-orphan-biovitrum , Sanofi

US FDA approves Sanofi-AstraZeneca's preventive RSV therapy for babies | WSAU News/Talk 550 AM · 99.9 FM

(Reuters) - U.S. Food and Drug Administration said on Monday it had approved Sanofi and partner AstraZeneca's antibody therapy to prevent respiratory ...

United-states , Bengaluru , Karnataka , India , Shinjini-ganguli , Raghav-mahobe , Bhanvi-satija , Reuters , Drug-administration , Astrazeneca , Swedish-orphan-biovitrum ,